Pierre Country
    • Homepage
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Author: Trevi Therapeutics, Inc.

Posted Date:

May 5, 2026
  • Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

    Trevi Therapeutics, Inc.
    May 5, 2026
  • Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference

    Trevi Therapeutics, Inc.
    April 30, 2026
  • Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026

    Trevi Therapeutics, Inc.
    April 28, 2026
  • Trevi Therapeutics to Participate in Upcoming May Events

    Trevi Therapeutics, Inc.
    April 23, 2026
  • Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

    Trevi Therapeutics, Inc.
    April 20, 2026
  • Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

    Trevi Therapeutics, Inc.
    April 16, 2026
  • Trevi Therapeutics Announces Proposed Public Offering of Common Stock

    Trevi Therapeutics, Inc.
    April 16, 2026
  • Trevi Therapeutics to Participate in Upcoming Events

    Trevi Therapeutics, Inc.
    April 1, 2026
  • Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

    Trevi Therapeutics, Inc.
    March 17, 2026
  • Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026

    Trevi Therapeutics, Inc.
    March 10, 2026
1 2
Next